by nms-sync | Feb 1, 2024 | News
New European Patent Office study: NMS srl top applicant in Italy during the 2002-2021 period
Nerviano, 1 February 2024 The new study “Patents and Innovation against Cancer”, just released today by the European Patent Office (EPO), reports Italy among...
by nms-sync | Jan 9, 2024 | News
NERVIANO, IT and BOSTON, Mass, 9 January, 2024 – Nerviano Medical Sciences S.r.l. (NMS), a part of NMS Group S.p.A. (NMS Group) and Nerviano Medical Sciences, Inc. (NMS-US), a wholly owned subsidiary of NMS Group, focused on the discovery and development of...
by nms-sync | Jan 8, 2024 | News
NERVIANO Italy and PARIS France, January 8, 2024 – Iktos, a company specialized in Artificial Intelligence for new drug design, and Nerviano Medical Sciences S.r.l (NMS), a leading Italian clinical stage biotech discovering and developing innovative therapies...
by nms-sync | Dec 20, 2023 | News
Nerviano Medical Sciences Srl (NMS) is pleased to announce the publication of the hot-off-the-press article “Photocatalytic Radical Coupling of Organoborates with α-Halogenated Electron-Poor Olefins” published in The Journal of Organic Chemistry...
by nms-sync | Dec 14, 2023 | News
NERVIANO and MILAN, Italy, December 14, 2023 – Nerviano Medical Sciences S.r.l. (NMS), a clinical-stage biotechnology company member of NMS group, announced the signing of a license agreement with Italfarmaco S.p.A. (ITF), a specialty pharmaceutical company, to...
Welcome and Check out our new motion picture!
Recent Comments